Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Graft-versus-host disease | R-HSA-1643685 | map05332 | tetraethylenepentamine | 3033637 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | tetraethylenepentamine | 3033637 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | tetraethylenepentamine | 3033637 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | tetraethylenepentamine | 3033637 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tetraethylenepentamine | 3033637 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | tetraethylenepentamine | 3033637 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tetraethylenepentamine | 3033637 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | tetraethylenepentamine | 3033637 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | tetraethylenepentamine | 3033637 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | tetraethylenepentamine | 3033637 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | tetraethylenepentamine | 3033637 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | tetraethylenepentamine | 3033637 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | clozapine | 135398737 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | clozapine | 135398737 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | clozapine | 135398737 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | clozapine | 135398737 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | clozapine | 135398737 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | clozapine | 135398737 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | clozapine | 135398737 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | clozapine | 135398737 | drug-path |